Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: outcomes of prolonged therapy.
Vasiliki
V
Pappa
Konstantinos
K
Girkas
Constantina
C
Sambani
Sotiris
S
Pagageorgiou
Panagiotis
P
Tsirigiotis
Kiki
K
Karvounis
Evangelia
E
Stathopoulou
Theofanis
T
Economopoulos
George
G
Dimitriadis
Ioannis
I
Dervenoulas
D059786:Abnormal Karyotype; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001374:Azacitidine / Q000008:administration & dosage*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000235:genetics; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D001374:Azacitidine